Log In
BCIQ
Print this Print this
 

ATX-MS-1467, M2736

  Manage Alerts
Collapse Summary General Information
Company Apitope International N.V.
DescriptionVaccine containing 4 synthetic peptides derived from human myelin basic protein
Molecular Target Major histocompatibility complex class II (MHCII)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat relapsing forms of multiple sclerosis (MS); Treat relapsing multiple sclerosis (MS); Treat secondary progressive multiple sclerosis (SPMS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
Get a free BioCentury trial today